Back to
First Eagle Investment Management, LLC
HALO
Showing 0 of 9 quarters
Position history for
First Eagle Investment Management, LLC's holdings in HALOZYME THERAPEUTICS INC
No. First Eagle Investment Management exited its HALO (Halozyme Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 483,800 shares worth $12.7M. First Eagle Investment Management already held HALO in its Q4 2018 13F, the earliest on record, and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.